Industry veterans stressed breaking silos, valuing consumer feedback and repositioning supply chain as a strategic business ...

On December 19, BofA raised its price target on Colgate-Palmolive Company (NYSE:CL) to $90 from $88 and kept a Buy rating.

With consumer staples stocks out of favor, Colgate-Palmolive's share price slumped in 2025. The company has accelerated its product development pace. Colgate-Palmolive has met or exceeded its organic ...

Colgate-Palmolive (CL) shares have been under pressure for over a year as slowing global category growth has weighed on the stock and ended the company’s run of organic sales at or above their ...

Colgate-Palmolive (CL) has slid about 16% over the past year, and that pullback is getting income focused investors to revisit this steady consumer staples name as a potential value and dividend play.

Procter & Gamble (NYSE: PG) stock has recently caught attention after Jim Cramer made a positive case for the stock. Both PG and its rival Colgate-Palmolive (CL) are down approximately 12% ...

Colgate-Palmolive returned to Newsweek's ranking of America's Most Responsible Companies for the fourth time this year.

Investing.com - Argus downgraded Colgate-Palmolive Company (NYSE:CL) from Buy to Hold on Thursday, citing margin pressures and minimal growth outlook. The consumer products giant, currently trading at ...

BofA raised the firm’s price target on Colgate-Palmolive (CL) to $90 from $88 and keeps a Buy rating on the shares. Entering 2026, the largest unresolved question for staples remains consumption ...

One island of stability in the sea of conversation about the future of work is the conviction that our jobs will become increasingly creative. The World Economic Forum, McKinsey, and nearly every ...

Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care, and Pet Nutrition segments. The Oral, Personal, and ...